Platelet-Activating Factor, PAF Acetylhydrolase, and Severe Anaphylaxis
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Vadas P, Gold M, Perelman B, et al. N Engl J Med. 2008;358(1):28–35 PURPOSE OF THE STUDY. To characterize the roles of platelet-activating factor (PAF) and PAF acetylhydrolase, the enzyme that inactivates PAF, in humans. STUDY POPULATION. The population was a variety of pediatric and adult patients with different levels of allergic disease along with nonallergic controls. METHODS. Serum PAF levels and activity of PAF acetylhydrolase were measured in 41 patients with anaphylaxis and in 23 control patients. Serum PAF acetylhydrolase activity was also measured in 9 patients with peanut allergy who had fatal anaphylaxis and compared with that in 26 nonallergic pediatric control patients, 49 nonallergic adult control patients, 63 children with mild peanut allergy, 24 patients with nonfatal anaphylaxis, 10 children who died of nonanaphylactic causes, 15 children with life-threatening asthma, and 19 children with non–life-threatening asthma. RESULTS. Mean serum PAF levels were significantly higher in patients with anaphylaxis than in patients in the control groups and were correlated with the severity of anaphylaxis. The proportion of subjects with elevated PAF levels increased from 4% in the control groups to 20% in the group with grade 1 anaphylaxis, 71% in the group with grade 2 anaphylaxis, and 100% in the group with grade 3 anaphylaxis. There was an inverse correlation between PAF levels and serum PAF acetylhydrolase activity. The proportion of patients with low PAF acetylhydrolase activity increased with the severity of anaphylaxis. Serum PAF acetylhydrolase activity was significantly lower in patients with fatal peanut anaphylaxis than in control patients. CONCLUSIONS. Serum PAF levels were directly correlated and serum PAF acetylhydrolase activity was inversely correlated with the severity of anaphylaxis. PAF acetylhydrolase activity was significantly lower in patients with fatal anaphylactic reactions to peanuts than in patients in any of the control groups. Failure of PAF acetylhydrolase to inactivate PAF may contribute to the severity of anaphylaxis. REVIEWER COMMENTS. PAF is 1 of the proinflammatory mediators that are released systemically by the degranulation of mast cells and basophils. Although PAF is not the only mediator that plays a role in anaphylaxis, these results suggest that PAF is very important. Therefore, it may be useful to develop new pharmaceutical agents that block its actions. Additional research is also needed to determine if PAF and PAF acetylhydrolase measurements may be used as a screening tool to select patients at highest risk for fatal anaphylaxis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Symposium on the Definition and Management of Anaphylaxis: Summary report
Sampson, H. A., Muñoz-Furlong, A., Bock, S. A., Schmitt, C., Bass, R., Chowdhury, B. A., Decker, W. W., Furlong, T. J., Galli, S. J., Golden, D. B., et al. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.01.009 · Cited by 641
Cited by
Dennis, E. A., Cao, J., Hsu, Y.-H., Magrioti, V., & Kokotos, G. (2011) · Chemical Reviews · doi:10.1021/cr200085w · Cited by 1,203
World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis
Simons, F. E. R., Ardusso, L. R. F., Bilò, M. B., El-Gamal, Y. M., Ledford, D. K., Ring, J., Sanchez-Borges, M., Senna, G. E., Sheikh, A., & Thong, B. Y. (2011) · World Allergy Organization Journal · doi:10.1097/wox.0b013e318211496c · Cited by 973
Properties of mouse and human IgG receptors and their contribution to disease models
Bruhns, P. (2012) · Blood · doi:10.1182/blood-2012-01-380121 · Cited by 847
The diagnosis and management of anaphylaxis practice parameter: 2010 Update
Lieberman, P., Nicklas, R. A., Oppenheimer, J., Kemp, S. F., Lang, D. M., Bernstein, D. I., Bernstein, J. A., Burks, A. W., Feldweg, A. M., Fink, J. N., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.022 · Cited by 739
Shaker, M. S., Wallace, D. V., Golden, D. B. K., Oppenheimer, J., Bernstein, J. A., Campbell, R. L., Dinakar, C., Ellis, A., Greenhawt, M., Khan, D. A., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.01.017 · Cited by 715
Valent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J. H., Carter, M. C., Castells, M., Escribano, L., Hartmann, K., Lieberman, P., et al. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000328760 · Cited by 654
World Allergy Organization anaphylaxis guidelines: Summary
Simons, F. E. R., Ardusso, L. R. F., Bilò, M. B., El-Gamal, Y. M., Ledford, D. K., Ring, J., Sanchez-Borges, M., Senna, G. E., Sheikh, A., & Thong, B. Y. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.038 · Cited by 570
Fatal Anaphylaxis: Mortality Rate and Risk Factors
Turner, P. J., Jerschow, E., Umasunthar, T., Lin, R., Campbell, D. E., & Boyle, R. J. (2017) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2017.06.031 · Cited by 546
Recent progress in phospholipase A2 research: From cells to animals to humans
Murakami, M., Taketomi, Y., Miki, Y., Sato, H., Hirabayashi, T., & Yamamoto, K. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.12.001 · Cited by 507
The pathophysiology of anaphylaxis
Reber, L. L., Hernandez, J. D., & Galli, S. J. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.06.003 · Cited by 507
Anaphylaxis—a practice parameter update 2015
Lieberman, P., Nicklas, R. A., Randolph, C., Oppenheimer, J., Bernstein, D., Bernstein, J., Ellis, A., Golden, D. B. K., Greenberger, P., Kemp, S., et al. (2015) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2015.07.019 · Cited by 474
Tordesillas, L., Berin, M. C., & Sampson, H. A. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.004 · Cited by 337
Mouse and human neutrophils induce anaphylaxis
Jönsson, F., Mancardi, D. A., Kita, Y., Karasuyama, H., Iannascoli, B., Van Rooijen, N., Shimizu, T., Daëron, M., & Bruhns, P. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45232 · Cited by 306
Human IgE-independent systemic anaphylaxis
Finkelman, F. D., Khodoun, M. V., & Strait, R. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.02.015 · Cited by 299
Pathogenesis of vascular leak in dengue virus infection
Malavige, G. N., & Ogg, G. S. (2017) · Immunology · doi:10.1111/imm.12748 · Cited by 285
Anaphylaxis: Clinical patterns, mediator release, and severity
Brown, S. G. A., Stone, S. F., Fatovich, D. M., Burrows, S. A., Holdgate, A., Celenza, A., Coulson, A., Hartnett, L., Nagree, Y., Cotterell, C., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.06.015 · Cited by 277
Umasunthar, T., Leonardi‐Bee, J., Hodes, M., Turner, P. J., Gore, C., Habibi, P., Warner, J. O., & Boyle, R. J. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12211 · Cited by 269
Stinging insect hypersensitivity
Golden, D. B. K., Demain, J., Freeman, T., Graft, D., Tankersley, M., Tracy, J., Blessing-Moore, J., Bernstein, D., Dinakar, C., Greenhawt, M., et al. (2017) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2016.10.031 · Cited by 267
Diagnosis and management of anaphylaxis in precision medicine
Castells, M. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.06.012 · Cited by 242
Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis
Vadas, P., Perelman, B., & Liss, G. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.08.016 · Cited by 223
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Valent, P., Akin, C., Bonadonna, P., Hartmann, K., Brockow, K., Niedoszytko, M., Nedoszytko, B., Siebenhaar, F., Sperr, W. R., Oude Elberink, J. N. G., et al. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.01.006 · Cited by 225
Understanding the mechanisms of anaphylaxis
Peavy, R. D., & Metcalfe, D. D. (2008) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e3283036a90 · Cited by 211
Nonredundant Roles of Basophils in Immunity
Karasuyama, H., Mukai, K., Obata, K., Tsujimura, Y., & Wada, T. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101257 · Cited by 211
A new framework for the interpretation of IgE sensitization tests
Roberts, G., Ollert, M., Aalberse, R., Austin, M., Custovic, A., DunnGalvin, A., Eigenmann, P. A., Fassio, F., Grattan, C., Hellings, P., et al. (2016) · Allergy · doi:10.1111/all.12939 · Cited by 98
Gülen, T., Akin, C., Bonadonna, P., Siebenhaar, F., Broesby-Olsen, S., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, H. N. G., Butterfield, J. H., et al. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2021.06.011 · Cited by 83
“Other potential markers that have been discussed in the context of MCA include heparin, serotonin, neuropeptides, platelet-activating factor, and chromogranin A (CgA).(13,71-76) However, there are insufficient data to demonstrate their clinical utility in the diagnosis of MCA and MCAS.”
BackgroundReaction Phenotypes in IgE-Mediated Food Allergy and Anaphylaxis
Chong, K. W., Ruiz-Garcia, M., Patel, N., Boyle, R. J., & Turner, P. J. (2020) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2019.12.023 · Cited by 44
Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?
Matito, A., & Carter, M. (2015) · Current Allergy and Asthma Reports · doi:10.1007/s11882-015-0525-1 · Cited by 39
Postural orthostatic tachycardia syndrome and the potential role of mast cell activation
Doherty, T. A., & White, A. A. (2018) · Autonomic Neuroscience · doi:10.1016/j.autneu.2018.05.001 · Cited by 37
Drug hypersensitivity in the fast lane
Jakubovic, B. D., Vecillas, L. D. L., Jimenez-Rodriguez, T. W., Sanchez-Sanchez, S., & Castells, M. (2020) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2020.04.005 · Cited by 33
Mast cell activation in the context of elevated basal serum tryptase: genetics and presentations
Khoury, P., & Lyons, J. J. (2019) · Current Allergy and Asthma Reports · doi:10.1007/s11882-019-0887-x · Cited by 30
Anaphylaxis: Mediators, Biomarkers, and Microenvironments
Fernandez-Bravo, S., Palacio-Garcia, L., Requena-Robledo, N., Yuste-Montalvo, A., Nuñez-Borque, E., & Esteban, V (2022) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0854 · Cited by 17
Metadata
- Authors
- Smart, B. A.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2008-11-01
- Volume
- 122
- Issue
- Supplement_4
- Pages
- S193-S194
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W4229620302
- Cited by
- 394
- References
- 1
- FWCI
- 18.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.